[HTML][HTML] Prostate cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019

L Wang, B Lu, M He, Y Wang, Z Wang… - Frontiers in Public …, 2022 - frontiersin.org
Aims To evaluate current status of prostate cancer incidence and mortality worldwide, and
compare the global trends of incidence and mortality in the past two decades and in the …

[PDF][PDF] 中国前列腺癌筛查与早诊早治指南(2022, 北京).

赫捷, 陈万青, 李霓, 曹巍, 叶定伟, 马建辉… - Chinese Journal of …, 2022 - jhxrmyy.com
前列腺癌是好发于老年男性的生殖系统恶性肿瘤. 前列腺癌高风险人群筛查与患者的早诊早治对
提高前列腺癌治愈率至关重要. 制定符合中国国情的前列腺癌筛查与早诊早治指南 …

Patient communication preferences for prostate cancer screening discussions: a scoping review

J Fong, M Venables, D D'Souza… - The Annals of Family …, 2023 - Annals Family Med
PURPOSE Prostate cancer screening guidelines have changed as new evidence showing
an equivocal mortality benefit led many organizations to relax recommendations for this …

[HTML][HTML] Canadian Urological Association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH): 2018 update

JC Nickel, L Aaron, J Barkin, D Elterman… - Canadian Urological …, 2018 - ncbi.nlm.nih.gov
The current document summarizes the state-of-the-art knowledge as it relates to
management of male lower urinary tract symptoms (MLUTS) secondary to benign prostatic …

[HTML][HTML] Screening for prostate cancer: protocol for updating multiple systematic reviews to inform a Canadian Task Force on Preventive Health Care guideline update

A Bennett, A Beck, N Shaver, R Grad, A LeBlanc… - Systematic …, 2022 - Springer
Purpose To inform updated recommendations by the Canadian Task Force on Preventive
Health Care on screening for prostate cancer in adults aged 18 years and older in primary …

[HTML][HTML] Update–2022 Canadian urological association recommendations on prostate cancer screening and early diagnosis: endorsement of the 2021 cancer care …

RJ Mason, K Marzouk, A Finelli, F Saad… - Canadian Urological …, 2022 - ncbi.nlm.nih.gov
Prostate cancer remains the most commonly diagnosed noncutaneous malignancy among
Canadian men and is the third leading cause of cancer-related death. In 2016, an estimated …

[HTML][HTML] UPDATE–Canadian Urological Association guideline: Male lower urinary tract symptoms/benign prostatic hyperplasia

D Elterman, M Aubé-Peterkin, H Evans… - Canadian Urological …, 2022 - ncbi.nlm.nih.gov
The current document summarizes the state-of-the-art knowledge as it relates to
management of male lower urinary tract symptoms (MLUTS) secondary to benign prostatic …

[HTML][HTML] Pumpkin seed oil (Cucurbita pepo) versus tamsulosin for benign prostatic hyperplasia symptom relief: a single-blind randomized clinical trial

N Zerafatjou, M Amirzargar, M Biglarkhani… - BMC urology, 2021 - Springer
Background Benign prostatic hyperplasia (BPH) is very common in aging men. We aimed to
compare the effects of tamsulosin and pumpkin (Cucurbita pepo) seed oil on BPH …

[HTML][HTML] Affinity captured urinary extracellular vesicles provide mRNA and miRNA biomarkers for improved accuracy of prostate cancer detection: a pilot study

M Davey, S Benzina, M Savoie, G Breault… - International journal of …, 2020 - mdpi.com
Serum prostate-specific antigen (sPSA) testing has helped to increase early detection of and
decrease mortality from prostate cancer. However, since sPSA lacks specificity, an invasive …

Disparities in prostate cancer screening, diagnoses, management, and outcomes between Indigenous and non‐Indigenous men in a universal health care system

A Kiciak, W Clark, M Uhlich, A Letendre, R Littlechild… - Cancer, 2023 - Wiley Online Library
Abstract Background Indigenous Peoples have higher morbidity rates and lower life
expectancies than non‐Indigenous Canadians. Identification of disparities between …